Eximo Medical Ltd. Sustainability Profile
Eximo Medical Ltd., headquartered in Israel, is a pioneering company in the medical device industry, specialising in innovative solutions for minimally invasive procedures. Founded in 2015, Eximo has rapidly established itself as a leader in the development of advanced laser technologies, particularly for vascular and interventional applications. The company’s flagship product, the Eximo Laser System, is renowned for its unique ability to deliver precise energy for effective tissue ablation, setting new standards in patient care and procedural efficiency. With a strong presence in Europe and North America, Eximo Medical Ltd. continues to expand its market reach, driven by a commitment to enhancing surgical outcomes and patient safety. Notable achievements include successful collaborations with leading healthcare institutions, further solidifying its position as a trusted innovator in the medical field.
DitchCarbon Score
How does Eximo Medical Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eximo Medical Ltd.'s score of 5 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eximo Medical Ltd.'s reported carbon emissions
Eximo Medical Ltd., headquartered in Israel (IL), currently does not have specific carbon emissions data available for reporting. The company is a current subsidiary of AngioDynamics, Inc., which may influence its climate commitments and emissions strategies. However, no specific reduction targets or climate pledges have been documented for Eximo Medical Ltd. at this time. As a subsidiary, Eximo Medical Ltd. may align its sustainability efforts with those of AngioDynamics, Inc., but specific details regarding emissions or reduction initiatives have not been disclosed. The absence of emissions data and defined climate commitments suggests that Eximo Medical Ltd. is in the early stages of developing its environmental strategy. In the context of the medical device industry, companies are increasingly focusing on sustainability and carbon reduction, and it is anticipated that Eximo Medical Ltd. will adopt similar practices in the future.
How Carbon Intensive is Eximo Medical Ltd.'s Industry?
How Carbon Intensive is Eximo Medical Ltd.'s Location?
Eximo Medical Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eximo Medical Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
